Loading…

The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium

Over-activation of the PI3K/Akt/mTOR network is a well-known pathogenic event that leads to hyper-proliferation. Pharmacological targeting of this pathway has been developed for the treatment of multiple diseases, including cancer. In polycystic kidney disease (PKD), the mTOR cascade promotes cyst g...

Full description

Saved in:
Bibliographic Details
Published in:Cellular signalling 2020-02, Vol.66, p.109468-109468, Article 109468
Main Authors: Margaria, Jean Piero, Campa, Carlo Cosimo, De Santis, Maria Chiara, Hirsch, Emilio, Franco, Irene
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c403t-4ddfc2b1a0cf7fbc7bc82226e1c8e7bac69d16c674ba0eda57f4919608081f233
cites cdi_FETCH-LOGICAL-c403t-4ddfc2b1a0cf7fbc7bc82226e1c8e7bac69d16c674ba0eda57f4919608081f233
container_end_page 109468
container_issue
container_start_page 109468
container_title Cellular signalling
container_volume 66
creator Margaria, Jean Piero
Campa, Carlo Cosimo
De Santis, Maria Chiara
Hirsch, Emilio
Franco, Irene
description Over-activation of the PI3K/Akt/mTOR network is a well-known pathogenic event that leads to hyper-proliferation. Pharmacological targeting of this pathway has been developed for the treatment of multiple diseases, including cancer. In polycystic kidney disease (PKD), the mTOR cascade promotes cyst growth by boosting proliferation, size and metabolism of kidney tubule epithelial cells. Therefore, mTOR inhibition has been tested in pre-clinical and clinical studies, but only the former showed positive results. This review reports recent discoveries describing the activity and molecular mechanisms of mTOR activation in tubule epithelial cells and cyst formation and discusses the evidence of an upstream regulation of mTOR by the PI3K/Akt axis. In particular, the complex interconnections of the PI3K/Akt/mTOR network with the principal signaling routes involved in the suppression of cyst formation are dissected. These interactions include the antagonism and the reciprocal negative regulation between mTOR complex 1 and the proteins whose deletion causes Autosomal Dominant PKD, the polycystins. In addition, the emerging role of phopshoinositides, membrane components modulated by PI3K, will be presented in the context of primary cilium signaling, cell polarization and protection from cyst formation. Overall, studies demonstrate that the activity of various members of the PI3K/Akt/mTOR network goes beyond the classical transduction of mitogenic signals and can impact several aspects of kidney tubule homeostasis and morphogenesis. These properties might be useful to guide the establishment of more effective treatment protocols to be tested in clinical trials. •Over-activation of the PI3K/Akt/mTOR pathway leads to hyper-proliferation in both cancer and kidney cysts•Successful outcome of mTOR inhibition in pre-clinical studies is not reproduced in clinical trials for PKD•Reciprocal regulation of mTOR-complex 1 and polycystin-1 affects kidney tubule homeostasis and PKD progression•Emerging role of PI3K-pathway members PIK3C2A and INPP5E in primary cilium-signalling and protection from cyst formation
doi_str_mv 10.1016/j.cellsig.2019.109468
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_475716</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0898656819302645</els_id><sourcerecordid>2314255956</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-4ddfc2b1a0cf7fbc7bc82226e1c8e7bac69d16c674ba0eda57f4919608081f233</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi1ERZeWnwDykUt2_RHbCRe0qvioqNSqWs6WY09Y7-arsdMl_56sEsqRk63R886M5kHoPSVrSqjcHNYWqir4X2tGaD7V8lRmr9CKZoonPKf8NVqRLM8SKWR2id6GcCCECiLZG3TJqaKCiXyFnnZ7wA-3_Mdme4ybenf_iDsT9yczYt_grq1GO4boLT5618CInQ9gAnzCW2zbuqvg98RF6I2Nvm3wycf9v1QTsGkc7npfm37E1ld-qK_RRWmqAO-W9wr9_Ppld_M9ubv_dnuzvUtsSnhMUudKywpqiC1VWVhV2IwxJoHaDFRhrMwdlVaqtDAEnBGqTHOaS5KRjJaM8yuUzH3DCbqh0MsWujVeL6Xj9AOdKqGonPiPM9_17dMAIerah_ONTQPtEDTjNGVC5OKMihm1fRtCD-VLc0r02Y4-6MWOPtvRs50p92EZMRQ1uJfUXx0T8HkGYDrMs4deB-uhseB8DzZq1_r_jPgD-E2leQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2314255956</pqid></control><display><type>article</type><title>The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium</title><source>ScienceDirect Journals</source><creator>Margaria, Jean Piero ; Campa, Carlo Cosimo ; De Santis, Maria Chiara ; Hirsch, Emilio ; Franco, Irene</creator><creatorcontrib>Margaria, Jean Piero ; Campa, Carlo Cosimo ; De Santis, Maria Chiara ; Hirsch, Emilio ; Franco, Irene</creatorcontrib><description>Over-activation of the PI3K/Akt/mTOR network is a well-known pathogenic event that leads to hyper-proliferation. Pharmacological targeting of this pathway has been developed for the treatment of multiple diseases, including cancer. In polycystic kidney disease (PKD), the mTOR cascade promotes cyst growth by boosting proliferation, size and metabolism of kidney tubule epithelial cells. Therefore, mTOR inhibition has been tested in pre-clinical and clinical studies, but only the former showed positive results. This review reports recent discoveries describing the activity and molecular mechanisms of mTOR activation in tubule epithelial cells and cyst formation and discusses the evidence of an upstream regulation of mTOR by the PI3K/Akt axis. In particular, the complex interconnections of the PI3K/Akt/mTOR network with the principal signaling routes involved in the suppression of cyst formation are dissected. These interactions include the antagonism and the reciprocal negative regulation between mTOR complex 1 and the proteins whose deletion causes Autosomal Dominant PKD, the polycystins. In addition, the emerging role of phopshoinositides, membrane components modulated by PI3K, will be presented in the context of primary cilium signaling, cell polarization and protection from cyst formation. Overall, studies demonstrate that the activity of various members of the PI3K/Akt/mTOR network goes beyond the classical transduction of mitogenic signals and can impact several aspects of kidney tubule homeostasis and morphogenesis. These properties might be useful to guide the establishment of more effective treatment protocols to be tested in clinical trials. •Over-activation of the PI3K/Akt/mTOR pathway leads to hyper-proliferation in both cancer and kidney cysts•Successful outcome of mTOR inhibition in pre-clinical studies is not reproduced in clinical trials for PKD•Reciprocal regulation of mTOR-complex 1 and polycystin-1 affects kidney tubule homeostasis and PKD progression•Emerging role of PI3K-pathway members PIK3C2A and INPP5E in primary cilium-signalling and protection from cyst formation</description><identifier>ISSN: 0898-6568</identifier><identifier>EISSN: 1873-3913</identifier><identifier>DOI: 10.1016/j.cellsig.2019.109468</identifier><identifier>PMID: 31715259</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Cancer ; Cell Proliferation ; Cilia - pathology ; Humans ; Kidney Tubules - metabolism ; Kidney Tubules - pathology ; mTOR ; Phosphatidylinositol 3-Kinases - metabolism ; Phosphoinositides ; PI3K ; PIK3C2A ; Polycystic kidney disease ; Polycystic Kidney Diseases - metabolism ; Polycystins ; Primary cilium ; Proto-Oncogene Proteins c-akt - metabolism ; Signal Transduction ; TOR Serine-Threonine Kinases - metabolism ; TRPP Cation Channels - metabolism</subject><ispartof>Cellular signalling, 2020-02, Vol.66, p.109468-109468, Article 109468</ispartof><rights>2019 Elsevier Inc.</rights><rights>Copyright © 2019 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-4ddfc2b1a0cf7fbc7bc82226e1c8e7bac69d16c674ba0eda57f4919608081f233</citedby><cites>FETCH-LOGICAL-c403t-4ddfc2b1a0cf7fbc7bc82226e1c8e7bac69d16c674ba0eda57f4919608081f233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31715259$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:142844610$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Margaria, Jean Piero</creatorcontrib><creatorcontrib>Campa, Carlo Cosimo</creatorcontrib><creatorcontrib>De Santis, Maria Chiara</creatorcontrib><creatorcontrib>Hirsch, Emilio</creatorcontrib><creatorcontrib>Franco, Irene</creatorcontrib><title>The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium</title><title>Cellular signalling</title><addtitle>Cell Signal</addtitle><description>Over-activation of the PI3K/Akt/mTOR network is a well-known pathogenic event that leads to hyper-proliferation. Pharmacological targeting of this pathway has been developed for the treatment of multiple diseases, including cancer. In polycystic kidney disease (PKD), the mTOR cascade promotes cyst growth by boosting proliferation, size and metabolism of kidney tubule epithelial cells. Therefore, mTOR inhibition has been tested in pre-clinical and clinical studies, but only the former showed positive results. This review reports recent discoveries describing the activity and molecular mechanisms of mTOR activation in tubule epithelial cells and cyst formation and discusses the evidence of an upstream regulation of mTOR by the PI3K/Akt axis. In particular, the complex interconnections of the PI3K/Akt/mTOR network with the principal signaling routes involved in the suppression of cyst formation are dissected. These interactions include the antagonism and the reciprocal negative regulation between mTOR complex 1 and the proteins whose deletion causes Autosomal Dominant PKD, the polycystins. In addition, the emerging role of phopshoinositides, membrane components modulated by PI3K, will be presented in the context of primary cilium signaling, cell polarization and protection from cyst formation. Overall, studies demonstrate that the activity of various members of the PI3K/Akt/mTOR network goes beyond the classical transduction of mitogenic signals and can impact several aspects of kidney tubule homeostasis and morphogenesis. These properties might be useful to guide the establishment of more effective treatment protocols to be tested in clinical trials. •Over-activation of the PI3K/Akt/mTOR pathway leads to hyper-proliferation in both cancer and kidney cysts•Successful outcome of mTOR inhibition in pre-clinical studies is not reproduced in clinical trials for PKD•Reciprocal regulation of mTOR-complex 1 and polycystin-1 affects kidney tubule homeostasis and PKD progression•Emerging role of PI3K-pathway members PIK3C2A and INPP5E in primary cilium-signalling and protection from cyst formation</description><subject>Cancer</subject><subject>Cell Proliferation</subject><subject>Cilia - pathology</subject><subject>Humans</subject><subject>Kidney Tubules - metabolism</subject><subject>Kidney Tubules - pathology</subject><subject>mTOR</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Phosphoinositides</subject><subject>PI3K</subject><subject>PIK3C2A</subject><subject>Polycystic kidney disease</subject><subject>Polycystic Kidney Diseases - metabolism</subject><subject>Polycystins</subject><subject>Primary cilium</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Signal Transduction</subject><subject>TOR Serine-Threonine Kinases - metabolism</subject><subject>TRPP Cation Channels - metabolism</subject><issn>0898-6568</issn><issn>1873-3913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkU1v1DAQhi1ERZeWnwDykUt2_RHbCRe0qvioqNSqWs6WY09Y7-arsdMl_56sEsqRk63R886M5kHoPSVrSqjcHNYWqir4X2tGaD7V8lRmr9CKZoonPKf8NVqRLM8SKWR2id6GcCCECiLZG3TJqaKCiXyFnnZ7wA-3_Mdme4ybenf_iDsT9yczYt_grq1GO4boLT5618CInQ9gAnzCW2zbuqvg98RF6I2Nvm3wycf9v1QTsGkc7npfm37E1ld-qK_RRWmqAO-W9wr9_Ppld_M9ubv_dnuzvUtsSnhMUudKywpqiC1VWVhV2IwxJoHaDFRhrMwdlVaqtDAEnBGqTHOaS5KRjJaM8yuUzH3DCbqh0MsWujVeL6Xj9AOdKqGonPiPM9_17dMAIerah_ONTQPtEDTjNGVC5OKMihm1fRtCD-VLc0r02Y4-6MWOPtvRs50p92EZMRQ1uJfUXx0T8HkGYDrMs4deB-uhseB8DzZq1_r_jPgD-E2leQ</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Margaria, Jean Piero</creator><creator>Campa, Carlo Cosimo</creator><creator>De Santis, Maria Chiara</creator><creator>Hirsch, Emilio</creator><creator>Franco, Irene</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20200201</creationdate><title>The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium</title><author>Margaria, Jean Piero ; Campa, Carlo Cosimo ; De Santis, Maria Chiara ; Hirsch, Emilio ; Franco, Irene</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-4ddfc2b1a0cf7fbc7bc82226e1c8e7bac69d16c674ba0eda57f4919608081f233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cancer</topic><topic>Cell Proliferation</topic><topic>Cilia - pathology</topic><topic>Humans</topic><topic>Kidney Tubules - metabolism</topic><topic>Kidney Tubules - pathology</topic><topic>mTOR</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Phosphoinositides</topic><topic>PI3K</topic><topic>PIK3C2A</topic><topic>Polycystic kidney disease</topic><topic>Polycystic Kidney Diseases - metabolism</topic><topic>Polycystins</topic><topic>Primary cilium</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Signal Transduction</topic><topic>TOR Serine-Threonine Kinases - metabolism</topic><topic>TRPP Cation Channels - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Margaria, Jean Piero</creatorcontrib><creatorcontrib>Campa, Carlo Cosimo</creatorcontrib><creatorcontrib>De Santis, Maria Chiara</creatorcontrib><creatorcontrib>Hirsch, Emilio</creatorcontrib><creatorcontrib>Franco, Irene</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Cellular signalling</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Margaria, Jean Piero</au><au>Campa, Carlo Cosimo</au><au>De Santis, Maria Chiara</au><au>Hirsch, Emilio</au><au>Franco, Irene</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium</atitle><jtitle>Cellular signalling</jtitle><addtitle>Cell Signal</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>66</volume><spage>109468</spage><epage>109468</epage><pages>109468-109468</pages><artnum>109468</artnum><issn>0898-6568</issn><eissn>1873-3913</eissn><abstract>Over-activation of the PI3K/Akt/mTOR network is a well-known pathogenic event that leads to hyper-proliferation. Pharmacological targeting of this pathway has been developed for the treatment of multiple diseases, including cancer. In polycystic kidney disease (PKD), the mTOR cascade promotes cyst growth by boosting proliferation, size and metabolism of kidney tubule epithelial cells. Therefore, mTOR inhibition has been tested in pre-clinical and clinical studies, but only the former showed positive results. This review reports recent discoveries describing the activity and molecular mechanisms of mTOR activation in tubule epithelial cells and cyst formation and discusses the evidence of an upstream regulation of mTOR by the PI3K/Akt axis. In particular, the complex interconnections of the PI3K/Akt/mTOR network with the principal signaling routes involved in the suppression of cyst formation are dissected. These interactions include the antagonism and the reciprocal negative regulation between mTOR complex 1 and the proteins whose deletion causes Autosomal Dominant PKD, the polycystins. In addition, the emerging role of phopshoinositides, membrane components modulated by PI3K, will be presented in the context of primary cilium signaling, cell polarization and protection from cyst formation. Overall, studies demonstrate that the activity of various members of the PI3K/Akt/mTOR network goes beyond the classical transduction of mitogenic signals and can impact several aspects of kidney tubule homeostasis and morphogenesis. These properties might be useful to guide the establishment of more effective treatment protocols to be tested in clinical trials. •Over-activation of the PI3K/Akt/mTOR pathway leads to hyper-proliferation in both cancer and kidney cysts•Successful outcome of mTOR inhibition in pre-clinical studies is not reproduced in clinical trials for PKD•Reciprocal regulation of mTOR-complex 1 and polycystin-1 affects kidney tubule homeostasis and PKD progression•Emerging role of PI3K-pathway members PIK3C2A and INPP5E in primary cilium-signalling and protection from cyst formation</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>31715259</pmid><doi>10.1016/j.cellsig.2019.109468</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0898-6568
ispartof Cellular signalling, 2020-02, Vol.66, p.109468-109468, Article 109468
issn 0898-6568
1873-3913
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_475716
source ScienceDirect Journals
subjects Cancer
Cell Proliferation
Cilia - pathology
Humans
Kidney Tubules - metabolism
Kidney Tubules - pathology
mTOR
Phosphatidylinositol 3-Kinases - metabolism
Phosphoinositides
PI3K
PIK3C2A
Polycystic kidney disease
Polycystic Kidney Diseases - metabolism
Polycystins
Primary cilium
Proto-Oncogene Proteins c-akt - metabolism
Signal Transduction
TOR Serine-Threonine Kinases - metabolism
TRPP Cation Channels - metabolism
title The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T16%3A01%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20PI3K/Akt/mTOR%20pathway%20in%20polycystic%20kidney%20disease:%20A%20complex%20interaction%20with%20polycystins%20and%20primary%20cilium&rft.jtitle=Cellular%20signalling&rft.au=Margaria,%20Jean%20Piero&rft.date=2020-02-01&rft.volume=66&rft.spage=109468&rft.epage=109468&rft.pages=109468-109468&rft.artnum=109468&rft.issn=0898-6568&rft.eissn=1873-3913&rft_id=info:doi/10.1016/j.cellsig.2019.109468&rft_dat=%3Cproquest_swepu%3E2314255956%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c403t-4ddfc2b1a0cf7fbc7bc82226e1c8e7bac69d16c674ba0eda57f4919608081f233%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2314255956&rft_id=info:pmid/31715259&rfr_iscdi=true